Trials / Completed
CompletedNCT00172029
Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 116 (actual)
- Sponsor
- Novartis · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this prospective, randomized, open-label, multicentric clinical study is to assess the effícacy and tolerability of zoledronic acid 4 mg IV infused over 15 minutes every 4 weeks for a total of 6 infusions, in combination with standard or reduced dose radiotherapy in patients with breast cancer and metastatic bone disease associated with pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zoledronic acid |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2005-09-01
- First posted
- 2005-09-15
- Last updated
- 2023-08-18
Locations
7 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00172029. Inclusion in this directory is not an endorsement.